APA (7th ed.) Citation

M, R., S, A., G, L., K, F., O, A., A, B., & I, A. (2026). Author Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort. Neurology, 106(10), e210239. https://doi.org/10.1212/WNL.0000000000210239

Chicago Style (17th ed.) Citation

M, Ringelstein, Asseyer S, Lindenblatt G, Fischer K, Aktas O, Berthele A, and Ayzenberg I. "Author Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort." Neurology 106, no. 10 (2026): e210239. https://doi.org/10.1212/WNL.0000000000210239.

MLA (9th ed.) Citation

M, Ringelstein, et al. "Author Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort." Neurology, vol. 106, no. 10, 2026, p. e210239, https://doi.org/10.1212/WNL.0000000000210239.